Brazilian multicenter study on pegvisomant treatment in acromegaly.
Cesar Luiz BoguszewskiMartha Katherine P HuayllasLucio Vilar Rabelo FilhoLuciana Ansaneli NavesAntonio Ribeiro-Oliveira JuniorBeatriz Santana SoaresMauro Antonio CzepielewskiJulio AbuchamSilvia Regina Correa-SilvaMarcello Delano BronsteinRaquel Soares JalladFelipe Gaia DuarteNina Rosa Castro MusolinoLeandro K J de PinhoMônica Roberto GadelhaPublished in: Archives of endocrinology and metabolism (2019)
In a real-life scenario, PEGV is a highly effective and safe treatment for acromegaly patients not controlled with other therapies.